|
CD9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.077800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.696300E-02 |
| Normal-vs-Stage2 |
3.459200E-01 |
| Normal-vs-Stage3 |
7.549800E-01 |
| Normal-vs-Stage4 |
9.880000E-01 |
| Stage1-vs-Stage2 |
1.432300E-02 |
| Stage1-vs-Stage3 |
8.812000E-02 |
| Stage1-vs-Stage4 |
7.014200E-02 |
| Stage2-vs-Stage3 |
2.157200E-01 |
| Stage2-vs-Stage4 |
3.852400E-01 |
| Stage3-vs-Stage4 |
7.770400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.469390E-01 |
| Normal-vs-AfricanAmerican |
4.722600E-01 |
| Normal-vs-Asian |
4.289800E-02 |
| Caucasian-vs-AfricanAmerican |
8.747200E-01 |
| Caucasian-vs-Asian |
2.184000E-01 |
| AfricanAmerican-vs-Asian |
3.340600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.122600E-01 |
| Normal-vs-Female |
2.195400E-01 |
| Male-vs-Female |
9.549600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.711910E-02 |
| Normal-vs-Age(41-60Yrs) |
1.774420E-01 |
| Normal-vs-Age(61-80Yrs) |
8.238000E-02 |
| Normal-vs-Age(81-100Yrs) |
8.619400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.182600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.80320000004097E-06 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.579400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.219600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.240200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.218000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.240300E-02 |
| Classical-VS-Follicular |
2.15609999965061E-07 |
| Classical-VS-Other |
8.552200E-01 |
| Classical-VS-Normal |
7.984100E-03 |
| Tall-VS-Follicular |
5.515900E-02 |
| Tall-VS-Other |
5.032000E-01 |
| Tall-VS-Normal |
9.657600E-01 |
| Follicular-VS-Other |
9.238000E-02 |
| Follicular-VS-Normal |
4.276400E-02 |
| Other-VS-Normal |
4.929800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.849800E-01 |
| Normal-vs-N1 |
5.417600E-01 |
| N0-vs-N1 |
6.345600E-01 |
|
|
